Concepedia

Shana Claeys

SC

Statistics

Publications

5

Citations

199

H-Index

5

Active since

2015

Affiliations

Ghent University Hospital(Current)

Heidelberg University

Essen University Hospital

German Cancer Research Center

Cancer Research Institute Ghent

Shana Claeys is an author at Ghent University Hospital specializing in oncology, oncogenic signaling pathways, and molecular biology.

Publications per year

2015–2020

5

Publications

5

Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment

Irina Lambertz, Candy Kumps, Shana Claeys et al. · Clinical Cancer Research · 2015 · 86 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma

Kristina B. Emdal, Anna-Kathrine Pedersen, Dorte B. Bekker‐Jensen et al. · Science Signaling · 2018 · 44 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness

Liselot Mus, Irina Lambertz, Shana Claeys et al. · Scientific Reports · 2020 · 28 citations · Full text

Medicine, Genetics, Oncology +17

ALK positively regulates MYCN activity through repression of HBP1 expression

Shana Claeys, Geertrui Denecker, Kaat Durinck et al. · Oncogene · 2018 · 25 citations · Full text

Life Sciences, Genetics, Molecular Biology +11

A high-throughput 3’ UTR reporter screening identifies microRNA interactomes of cancer genes

Gert Van Peer, Evelien Mets, Shana Claeys et al. · PLoS ONE · 2018 · 16 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

1–5 of 5